Is Life Science industry healthy?

3 min read

Photo by Hal Gatewood on Unsplash

“Shoemaker’s son always goes barefoot” Anyone reading the news about Life Science companies would believe that everything is OK for them, with billions of dollars in revenue and cash on hand. The reality is that industry fundamentals are shifting, and their future may look different than it does today. While the life sciences business has steadily integrated technologies over the years, the pandemic has increased the innovation demand to unprecedented levels. Top-tier pharmaceutical companies have expedited collaborations and acquisitions, although they could not avoid new brave entrants rattling the industry ranking: A first for a sector shielded from outside investment…...

This article is free to read

Login to read the full article


By subscribing to our main site, you will also be subscribed to DDIntel - our regular letter showcasing our featured articles and applications.

Flavio Aliberti Flavio Aliberti brings with him a 23-year track record in consulting around business intelligence, change management, strategy, M&A transformation, IT and SOX auditing for high regulated domains, like Insurance, Airlines, Trade Associations, Automotive, and Pharma. He holds an MSc in Space Aeronautic Engineering from the University of Naples and an MSc in Advanced Information Technology and Business Management from the University of Wales.